Characterization of mutations conferring extensive drug resistance to Mycobacterium tuberculosis isolates in Pakistan

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 12, 2011, Pages 5654-5659

  Ali, Asho ^a   Hasan, Rumina ^a   Jabeen, Kauser ^a   Jabeen, Nusrat ^a   Qadeer, Ejaz ^b   Hasan, Zahra ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b National Tuberculosis Control Programme   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CAPREOMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ADULT; AFRICA; ARTICLE; ASIA; BACTERIAL GENE; BACTERIUM ISOLATION; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; HUMAN; MALE; MOLECULAR DIAGNOSIS; MYCOBACTERIUM TUBERCULOSIS; PAKISTAN; PRIORITY JOURNAL;

ADULT; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PAKISTAN; TUBERCULOSIS, PULMONARY;

EID: 81555206718     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05101-11     Document Type: Article

References (56)

1. Adams, K. N., et al. 2011. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145:39-53.
2. Agonafir, M., et al. 2010. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia. Int. J. Tuberc. Lung Dis. 14:1259-1265.
3. Ahmad, S., E. Fares, G. F. Araj, T. D. Chugh, and A. S. Mustafa. 2002. Prevalence of S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Dubai and Beirut. Int. J. Tuberc. Lung Dis. 6:920-926. (Pubitemid 35190707)
4. Ajbani, K., C. Rodrigues, S. Shenai, and A. Mehta. 2011. Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India. J. Clin. Microbiol. 49:1588-1590.
5. Alangaden, G. J., et al. 1998. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 42:1295-1297. (Pubitemid 28227943)
6. Ali, A., Z. Hasan, T. Moatter, M. Tanveer, and R. Hasan. 2009. M. tuberculosis Central Asian Strain 1 MDR isolates have more mutations in rpoB and katG genes compared with other genotypes. Scand. J. Infect. Dis. 41: 37-44.
7. Almeida, D., et al. 2005. High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin. Infect. Dis. 40:881-886. (Pubitemid 40365511)
8. Baldeviano-Vidalon, G. C., et al. 2005. Multiple infection with resistant and sensitive M. tuberculosis strains during treatment of pulmonary tuberculosis patients. Int. J. Tuberc. Lung Dis. 9:1155-1160. (Pubitemid 41433806)
9. Banerjee, A., et al. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230. (Pubitemid 24067929)
10. Reference deleted.
11. Brossier, F., N. Veziris, A. Aubry, V. Jarlier, and W. Sougakoff. 2010. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 48:1683-1689.
12. Campbell, P. J., et al. 2011. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 55:2032-2041.
13. Cardoso, R. F., et al. 2004. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob. Agents Chemother. 48:3373-3381. (Pubitemid 39129333)
14. Cui, Z., J. Wang, J. Lu, X. Huang, and Z. Hu. 2011. Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009. BMC Infect. Dis. 11:78.
15. Dukes Hamilton, C., et al. 2007. Extensively drug-resistant tuberculosis: are we learning from history or repeating it? Clin. Infect. Dis. 45:338-342.
16. Ejaz, M., et al. 2010. Prevalence of multi-drug resistant tuberculosis in Karachi, Pakistan: identification of at risk groups. Trans. R. Soc. Trop. Med. Hyg. 104:511-517.
17. Evans, J., and H. Segal. 2010. Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 65:897-900.
18. Feuerriegel, S., et al. 2009. Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrob. Agents Chemother. 53:3353-3356.
19. Filliol, I., et al. 2002. Global distribution of Mycobacterium tuberculosis spoligotypes. Emerg. Infect. Dis. 8:1347-1349. (Pubitemid 35334712)
20. Filliol, I., et al. 2003. Snapshot of moving and expanding clones of Mycobacterium tuberculosis and their global distribution assessed by spoligotyping in an international study. J. Clin. Microbiol. 41:1963-1970. (Pubitemid 36576521)
21. Gandhi, N. R., et al. 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368:1575-1580. (Pubitemid 44780738)
22. Gandhi, N. R., et al. 2010. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375:1830-1843.
23. Ghebremichael, S., et al. 2010. Drug resistant Mycobacterium tuberculosis of the Beijing genotype does not spread in Sweden. PLoS One 5:e10893.
24. Ginsburg, A. S., et al. 2003. The rapid development of fluoroquinolone resistance in M. tuberculosis. N. Engl. J. Med. 349:1977-1978. (Pubitemid 37409723)
25. Glynn, J. R., J. Whiteley, P. J. Bifani, K. Kremer, and D. van Soolingen. 2002. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg. Infect. Dis. 8:843-849.
26. Gutierrez, M. C., et al. 2006. Predominance of ancestral lineages of Mycobacterium tuberculosis in India. Emerg. Infect. Dis. 12:1367-1374. (Pubitemid 44462680)
27. Hasan, R., et al. 2010. Extensively drug-resistant tuberculosis, Pakistan. Emerg. Infect. Dis. 16:1473-1475.
28. Hillemann, D., S. Rusch-Gerdes, and E. Richter. 2007. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 45:2635-2640. (Pubitemid 47295497)
29. Honore-Bouakline, S., J. P. Vincensini, V. Giacuzzo, P. H. Lagrange, and J. L. Herrmann. 2003. Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J. Clin. Microbiol. 41:2323-2329. (Pubitemid 36712431)
30. Johnson, R., et al. 2010. Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int. J. Tuberc. Lung Dis. 14:119-121.
31. Reference deleted.
32. Jugheli, L., et al. 2009. High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrob. Agents Chemother. 53:5064-5068.
33. Kelley, C. L., D. A. Rouse, and S. L. Morris. 1997. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41:2057-2058. (Pubitemid 27383260)
34. Khanna, A., et al. 2010. Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India. Antimicrob. Agents Chemother. 54:4789-4793.
35. Kiet, V. S., et al. 2010. Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 48:2934-2939.
36. Ling, D. I., A. A. Zwerling, and M. Pai. 2008. Rapid diagnosis of drug-resistant TB using line probe assays: from evidence to policy. Expert Rev. Respir. Med. 2:583-588.
37. Lipin, M. Y., V. N. Stepanshina, I. G. Shemyakin, and T. M. Shinnick. 2007. Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. Clin. Microbiol. Infect. 13:620-626. (Pubitemid 46730669)
38. Ma, X., et al. 2006. rpoB Gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J. Clin. Microbiol. 44:3409-3412. (Pubitemid 44413791)
39. Maus, C. E., B. B. Plikaytis, and T. M. Shinnick. 2005. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:3192-3197. (Pubitemid 41060560)
40. Musser, J. M. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:496-514.
41. Niemann, S., et al. 2010. Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia. J. Clin. Microbiol. 48:3544-3550.
42. Perdigao, J., et al. 2010. Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal. J. Antimicrob. Chemother. 65:224-227.
43. Shah, N. S., et al. 2007. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg. Infect. Dis. 13:380-387. (Pubitemid 46348124)
44. Sreevatsan, S., et al. 1997. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc. Natl. Acad. Sci. U. S. A. 94:9869-9874. (Pubitemid 27408157)
45. Srivastava, S., et al. 2010. Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol. J. Infect. Dis. 201:1225-1231.
46. Stavrum, R., V. P. Myneedu, V. K. Arora, N. Ahmed, and H. M. Grewal. 2009. In-depth molecular characterization of Mycobacterium tuberculosis from New Delhi-predominance of drug resistant isolates of the 'modern'(TbD1) type. PLoS One 4:e4540.
47. Sun, Z., et al. 2008. Characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates in China. J. Clin. Microbiol. 46:4075-4077.
48. Takiff, H. E., et al. 1994. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother. 38:773-780. (Pubitemid 24114017)
49. Tanveer, M., et al. 2008. Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan. BMC Infect. Dis. 8:171.
50. Telenti, A., et al. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650. (Pubitemid 23083244)
51. Torres, M. J., A. Criado, M. Ruiz, J. C. Palomares, and J. Aznar. 2003. Improved real-time PCR for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates. Diagn. Microbiol. Infect. Dis. 45:2007-2012.
52. WHO. 2010. Multidrug and extensively drug-resistant tuberculosis: 2010 Global Report on Surveillance and Response. World Health Organization, Geneva, Switzerland.
53. WHO. 2008. Rapid tests for drug-resistant TB to be available in developing countries. World Health Organization, Geneva, Switzerland. http://www.who .int/tb/features-archive/mdrtb-rapid-tests/en/index.html.
54. Woods, G. L., et al. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes: approved standard. Document no. M24-A. NCCLS, Wayne, PA.
55. Zaunbrecher, M. A., R. D. Sikes, Jr., B. Metchock, T. M. Shinnick, and J. E. Posey. 2009. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 106:20004-20009.
56. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591-593.